Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase

Journal of Laboratory and Clinical Medicine

Volumn 147, Issue 4, 2006, Pages 167-173

  Brodin, Ellen ^a   Iversen, Nina ^b   Hansen, John Bjarne ^a  

^a Institute of Clinical Medicine   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIPOPROTEIN LIPASE; TISSUE FACTOR PATHWAY INHIBITOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CELL IMMORTALIZATION; CELL ISOLATION; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIUM CELL; FATTY ACID BLOOD LEVEL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENTIAL ANALYSIS; ULTRACENTRIFUGATION; UPREGULATION;

CELL LINE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; HUMANS; HYDROLYSIS; KINETICS; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIPOPROTEINS, VLDL; RECOMBINANT PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 33645888119     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.11.010     Document Type: Article

References (35)

1. Rapaport S.I., and Rao L.V. The tissue factor pathway. how it has become a "prima ballerina.". Thromb Haemost 74 (1995) 7-17
2. Broze Jr. G.J., and Miletich J.P. Characterization of the inhibition of tissue factor in serum. Blood 69 (1987) 150-155
3. Rao L.V., and Rapaport S.I. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 69 (1987) 645-651
4. Bajaj M.S., Kuppuswamy M.N., Saito H., Spitzer S.G., and Bajaj S.P. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor. evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 87 (1990) 8869-8873
5. Sandset P.M., Abildgaard U., and Larsen M.L. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 50 (1988) 803-813
6. Lindahl A.K., Abildgaard U., and Staalesen R. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor. Thromb Res 64 (1991) 155-168
7. Novotny W.F., Palmier M., Wun T.C., Broze Jr. G.J., and Miletich J.P. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood 78 (1991) 394-400
8. Goldberg I.J. Lipoprotein lipase and lipolysis. central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37 (1996) 693-707
9. Bengtsson-Olivecrona G.O.T. Assay of lipoprotein lipase and hepatic lipase. In: Rickwood R., and Hames B.D. (Eds). The practical Approche Series (1992), Oxford University Press, Oxford, U.K
10. Preiss-Landl K., Zimmermann R., Hammerle G., and Zechner R. Lipoprotein lipase. the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 13 (2002) 471-481
11. Grundy S.M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81 (1998) 18B-25B
12. Davignon J., and Cohn J.S. Triglycerides. a risk factor for coronary heart disease. Atherosclerosis 124 suppl (1996) S57-S64
13. Hansen J.B., Grimsgaard S., Huseby N., Sandset P.M., and Bonaa K.H. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men. Thromb Res 102 (2001) 3-13
14. Kawaguchi A., Miyao Y., Noguchi T., Nonogi H., Yamagishi M., Miyatake K., et al. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II. Arterioscler Thromb Vasc Biol 20 (2000) 251-258
15. Hansen J.B., Huseby N.E., Sandset P.M., Svensson B., Lyngmo V., and Nordoy A. Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb 14 (1994) 223-229
16. Kokawa T., Abumiya T., Kimura T., Harada-Shiba M., Koh H., Tsushima M., et al. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler Thromb Vasc Biol 15 (1995) 504-510
17. Mukherjee M., and Kakkar V.V. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor. Thromb Haemost 82 (1999) 1648-1651
18. Redgrave T.G., Roberts D.C., and West C.E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65 (1975) 42-49
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
20. Mutin M., gnat-George F., and Sampol J. Immunologic phenotype of cultured endothelial cells. quantitative analysis of cell surface molecules. Tissue Antigens 50 (1997) 449-458
21. Zhang J., Piro O., Lu L., and Broze Jr. G.J. Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation 108 (2003) 623-627
22. Hansen J.B., Svensson B., Olsen R., Ezban M., Osterud B., and Paulssen R.H. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. Thromb Haemost 83 (2000) 937-943
23. Piro O., and Broze Jr. G.J. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding. Circulation 110 (2004) 3567-3572
24. Johansen T., Bjorkoy G., Overvatn A., az-Meco M.T., Traavik T., and Moscat J. NIH 3T3 cells stably transfected with the gene encoding phosphatidylcholine-hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. Mol Cell Biol 14 (1994) 646-654
25. Markwell M.A. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem 125 (1982) 427-432
26. Nilsson L., Gafvels M., Musakka L., Ensler K., Strickland D.K., Angelin B., et al. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression. involvement of the VLDL receptor. J Lipid Res 40 (1999) 913-919
27. Kawaguchi A., Miyao Y., Noguchi T., Nonogi H., Yamagishi M., Miyatake K., et al. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II. Arterioscler Thromb Vasc Biol 20 (2000) 251-258
28. Pritchard Jr. K.A., Schwarz S.M., Medow M.S., and Stemerman M.B. Effect of low-density lipoprotein on endothelial cell membrane fluidity and mononuclear cell attachment. Am J Physiol 260 (1991) C43-C49
29. Rabini R.A., Vignini A., Salvolini E., Staffolani R., Martarelli D., Moretti N., et al. Activation of human aortic endothelial cells by LDL from Type 1 diabetic patients. an in vitro study. Atherosclerosis 165 (2002) 69-77
30. Norata G.D., Pirillo A., Callegari E., Hamsten A., Catapano A.L., and Eriksson P. Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res 59 (2003) 169-180
31. Stiko-Rahm A., Wiman B., Hamsten A., and Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10 (1990) 1067-1073
32. Hansen J.B., Olsen R., and Webster P. Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells. Blood 90 (1997) 3568-3578
33. Iversen N., Sandset P.M., Abildgaard U., and Torjesen P.A. Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans. Thromb Res 84 (1996) 267-278
34. Ott I., Miyagi Y., Miyazaki K., Heeb M.J., Mueller B.M., Rao L.V., et al. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 20 (2000) 874-882
35. Lookene A., Chevreuil O., Ostergaard P., and Olivecrona G. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate. stoichiometry, stabilization, and kinetics. Biochemistry 35 (1996) 12155-12163